Bipolar Disorder & Polygraph Tests: Examiner & Examinee Guide

What Is Bipolar Disorder?

Bipolar disorder is a chronic psychiatric condition characterized by significant fluctuations in mood, energy, activity levels, and the ability to carry out daily tasks. Classified in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) as a distinct category of mood disorders, bipolar disorder lies on a spectrum between unipolar depressive disorders and schizophrenia spectrum disorders [1]Verified Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Confirms diagnostic criteria for Bipolar I, Bipolar II, Cyclothymic Disorder, and mixed features specifier.

The condition affects approximately 2.8% of the adult population in the United States, according to the National Institute of Mental Health (NIMH) [2]Verified Bipolar Disorder Statistics
Confirms 2.8% past-year prevalence of bipolar disorder among U.S. adults from NCS-R data. Globally, the World Health Organization estimates that approximately 37 million people live with bipolar disorder [3]Verified Bipolar Disorder Fact Sheet
Confirms estimated 37 million people worldwide live with bipolar disorder as of 2021. The prevalence has been rising, with the Global Burden of Disease Study 2021 documenting a steady increase in incident cases worldwide [4]Verified Global, regional, and national burden of bipolar disorder, 1990–2021
Confirms global incidence of bipolar disorder has been steadily increasing, rising from 30 million cases in 1990 to nearly 54 million in 2021. Bipolar disorder typically emerges in late adolescence or early adulthood, with an average age of onset around 25 years, though it can appear in childhood or later in life [5]Verified Bipolar disorders: an update on critical aspects
Confirms average age of onset peaks at 17, 26, and 42 years, and that prevalence has risen 59.3% since 1990.

For polygraph professionals, understanding bipolar disorder is essential because the condition fundamentally alters the autonomic nervous system (ANS) responses that polygraph instruments measure. Unlike many other psychological conditions, bipolar disorder involves episodic, dramatic shifts in physiological baseline that examiners rely on to differentiate between truthful and deceptive responses. For a comprehensive overview of how polygraph instruments work, see our complete guide to polygraph testing.

Bipolar I Disorder

Bipolar I is defined by the occurrence of at least one manic episode lasting seven or more days (or requiring hospitalization), often accompanied by depressive episodes lasting at least two weeks. Manic episodes in Bipolar I are typically severe and may include psychotic features such as delusions of grandeur, hallucinations, or severely impaired judgment [1]Verified Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Confirms diagnostic criteria for Bipolar I, Bipolar II, Cyclothymic Disorder, and mixed features specifier.

From a polygraph perspective, Bipolar I presents the most significant challenges because full manic episodes produce the most extreme autonomic dysregulation. Individuals experiencing active mania may exhibit pressured speech, racing thoughts, decreased need for sleep, and dramatically elevated sympathetic nervous system activity [6]Verified Heart rate variability in bipolar mania and schizophrenia
Confirms manic BD patients demonstrated significant reduction in HRV, parasympathetic activity, and cardiac entropy compared to healthy controls. All of these can overwhelm the polygraph instrument's ability to differentiate between stress responses to relevant versus comparison questions.

Additionally, the psychotic features that can accompany severe manic episodes may compromise the examinee's ability to understand questions, provide consistent answers, or maintain the cognitive focus required for a valid examination. The APA's Model Policy for the Evaluation of Examinee Suitability specifically notes that persons who are actively psychotic should not undergo polygraph testing [7]Verified APA Standards of Practice
Confirms examiners should make reasonable efforts to determine suitability and make basic inquiries into medical and psychological condition. Examiners who encounter an individual in an active Bipolar I manic state should recognize this as a clear contraindication for testing.

Bipolar II Disorder

Bipolar II is characterized by at least one hypomanic episode (a less severe form of mania lasting at least four days) and at least one major depressive episode [1]Verified Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Confirms diagnostic criteria for Bipolar I, Bipolar II, Cyclothymic Disorder, and mixed features specifier. Hypomania does not include psychotic features and does not cause the severe functional impairment seen in full mania, though it still involves elevated mood, increased energy, decreased need for sleep, and heightened productivity or irritability.

For polygraph testing purposes, Bipolar II presents a more nuanced challenge. Hypomanic states may cause subtler autonomic changes that could affect physiological baselines without being immediately obvious to the examiner. An individual in a hypomanic state may appear confident, articulate, and cooperative, potentially masking the underlying physiological dysregulation that compromises test validity. This makes careful pre-test assessment particularly important for Bipolar II examinees.

The depressive episodes in Bipolar II tend to be more frequent and longer-lasting than in Bipolar I, meaning that many Bipolar II examinees may present in a depressed state, which carries its own set of challenges for polygraph accuracy as discussed later in this guide.

Cyclothymic Disorder and Other Specified Bipolar Disorders

Cyclothymia involves chronic fluctuating moods with periods of hypomanic symptoms and periods of depressive symptoms that do not meet the full criteria for hypomania or major depression. These fluctuations persist for at least two years in adults [1]Verified Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Confirms diagnostic criteria for Bipolar I, Bipolar II, Cyclothymic Disorder, and mixed features specifier. While less severe than Bipolar I or II, cyclothymia can still produce measurable autonomic variability that may affect polygraph baseline stability.

The DSM-5 also includes categories for substance/medication-induced bipolar disorder and bipolar disorder due to another medical condition, both of which may be encountered in forensic polygraph settings. Examiners should be aware that bipolar symptoms can be triggered or exacerbated by substance use, which adds another layer of complexity to suitability assessment. Understanding these distinctions helps examiners make more informed decisions about whether to proceed with, modify, or defer an examination. For a broader perspective on conditions that intersect with polygraph work, see our guide on OCD and polygraph testing.

Why the ANS Matters for Polygraph Testing

Polygraph instruments measure physiological responses governed by the autonomic nervous system (ANS), specifically changes in respiration rate and depth, electrodermal activity (skin conductance), cardiovascular measures (blood pressure, heart rate, pulse amplitude), and in some cases, finger pulse or peripheral vasomotor activity [8]Verified Federal Psychophysiological Detection of Deception Examiner Handbook
Standardized testing procedures, scoring methods, and quality assurance requirements for federal polygraph programs. These measures reflect the balance between the sympathetic nervous system (the "fight or flight" response) and the parasympathetic nervous system (the "rest and digest" response).

During a standard polygraph examination, the examiner establishes a physiological baseline during neutral questions and then monitors for significant deviations when relevant questions are asked. The fundamental assumption is that deception produces a measurable increase in sympathetic nervous system activity, manifesting as increased electrodermal response, changes in blood pressure, altered respiratory patterns, and other autonomic indicators [9]Verified The Reliability of Polygraph Examiner Diagnosis of Truth and Deception
Seminal study demonstrating high inter-rater reliability for experienced examiners using structured scoring methods. Research has confirmed that electrodermal (GSR) measures provide the most diagnostic information among the individual physiological channels, followed by cardiovascular and respiratory channels [10]Verified Relative Accuracy of Polygraph Examiner Diagnosis of Respiration, Blood Pressure, and GSR Recordings
Confirms electrodermal (GSR) measures provide the most diagnostic information, followed by cardiovascular and respiratory channels.

Bipolar disorder fundamentally disrupts this baseline-deviation model because the condition itself alters ANS functioning in ways that can produce physiological patterns similar to those associated with deception. Understanding how to identify what a polygraph machine looks for is essential context for appreciating these challenges.

Autonomic Dysregulation in Bipolar Disorder

Research has consistently demonstrated that individuals with bipolar disorder exhibit significant ANS dysregulation that persists across mood states, though the nature and severity vary dramatically depending on whether the individual is in a manic, depressive, or euthymic (stable) phase.

A landmark study by Henry, Minassian, Paulus, Geyer, and Perry (2010) assessed heart rate variability (HRV) in acutely hospitalized manic bipolar patients compared to healthy controls. Manic patients demonstrated a significant reduction in HRV, parasympathetic activity, and cardiac entropy compared to healthy subjects [6]Verified Heart rate variability in bipolar mania and schizophrenia
Confirms manic BD patients demonstrated significant reduction in HRV, parasympathetic activity, and cardiac entropy compared to healthy controls. This finding was further supported by a comprehensive systematic review and meta-analysis by Faurholt-Jepsen, Kessing, and Munkholm (2017), published in Neuroscience & Biobehavioral Reviews, which included 15 articles comprising 2,534 individuals and found that HRV was significantly reduced in bipolar disorder compared to healthy controls (g=-1.77, 95% CI: -2.46 to -1.09, P<0.001) [11]Verified Heart rate variability in bipolar disorder: A systematic review and meta-analysis
Confirms HRV was significantly reduced in BD compared to healthy controls (g=-1.77), based on 15 articles and 2,534 individuals.

These findings have important implications for polygraph testing because they mean that even "stable" bipolar patients may have slightly different autonomic baselines compared to the general population. However, the magnitude of this euthymic-state difference is generally small enough that experienced examiners can establish valid baselines and conduct reliable examinations, provided the individual is genuinely in a stable phase [11]Verified Heart rate variability in bipolar disorder: A systematic review and meta-analysis
Confirms HRV was significantly reduced in BD compared to healthy controls (g=-1.77), based on 15 articles and 2,534 individuals. The critical concern arises when mood episodes are active, producing dramatic autonomic changes that can overwhelm the polygraph's discriminative capacity.

The Sympathetic-Parasympathetic Balance

In healthy individuals, the sympathetic and parasympathetic nervous systems operate in a dynamic balance, with the parasympathetic system dominant during rest and the sympathetic system activating in response to stress, novelty, or perceived threat. Polygraph testing leverages the sympathetic activation that accompanies deception-related anxiety [8]Verified Federal Psychophysiological Detection of Deception Examiner Handbook
Standardized testing procedures, scoring methods, and quality assurance requirements for federal polygraph programs.

In bipolar disorder, this balance is disrupted in mood-state-dependent ways:

During mania, the sympathetic nervous system is chronically hyperactivated, producing elevated baseline arousal that may not further increase significantly in response to relevant questions. This can create a "ceiling effect" where the already-elevated sympathetic state leaves little room for the additional activation that typically signals deception [6]Verified Heart rate variability in bipolar mania and schizophrenia
Confirms manic BD patients demonstrated significant reduction in HRV, parasympathetic activity, and cardiac entropy compared to healthy controls.

During depression, the parasympathetic system may become dominant, or overall autonomic responsiveness may be blunted, producing reduced physiological reactivity across all question types. Research on electrodermal activity in bipolar disorder has shown that patients with bipolar depression exhibit significantly reduced EDA, which increases to levels similar to euthymia or healthy controls after clinical remission [12]Verified Electrodermal activity in bipolar disorder: Differences between mood episodes and clinical remission
Confirms bipolar depression showed significantly reduced EDA that increased after remission; manic patients showed significant reduction of EDA after remission. This can create a "floor effect" where responses to relevant questions fail to differentiate from responses to comparison questions.

During euthymia, the sympathetic-parasympathetic balance is closer to normal, though some residual dysregulation may persist [11]Verified Heart rate variability in bipolar disorder: A systematic review and meta-analysis
Confirms HRV was significantly reduced in BD compared to healthy controls (g=-1.77), based on 15 articles and 2,534 individuals. This represents the optimal testing window for most bipolar examinees.

Physiological Hallmarks of Mania

Manic episodes produce a constellation of physiological changes that directly interfere with polygraph measurement channels. Understanding these changes is essential for examiners who may encounter a bipolar examinee in or near a manic state.

Elevated electrodermal activity (EDA): Mania is associated with increased sympathetic innervation of the eccrine sweat glands, producing elevated tonic skin conductance levels and increased frequency of non-specific skin conductance responses (NS-SCRs). During a polygraph examination, these spontaneous fluctuations create noise that obscures the specific responses to relevant questions, making it extremely difficult to apply standard scoring criteria reliably. The spontaneous fluctuation rate during mania can be dramatically elevated compared to normal ranges.

Cardiovascular hyperactivation: Manic states are associated with increased heart rate, elevated blood pressure, and altered pulse wave morphology. The elevated cardiovascular baseline during mania means that the relative increases typically accompanying deception may be absent or indistinguishable from the already-elevated background activity [6]Verified Heart rate variability in bipolar mania and schizophrenia
Confirms manic BD patients demonstrated significant reduction in HRV, parasympathetic activity, and cardiac entropy compared to healthy controls.

Respiratory irregularity: Mania often produces irregular breathing patterns, including rapid shallow breathing, sighing, and inconsistent respiratory rhythms. Since polygraph scoring relies on comparing respiratory patterns between relevant and comparison questions, baseline respiratory instability renders respiratory channel data unreliable.

Motor restlessness: Psychomotor agitation during mania can produce movement artifacts that contaminate all physiological channels. Fidgeting, shifting in the chair, and inability to remain still not only create direct artifacts but also indicate the level of autonomic activation compromising data quality.

False Positive Risk During Mania

The primary risk of conducting a polygraph examination during a manic episode is the production of false positive results, where a truthful individual is incorrectly classified as deceptive. This occurs because the physiological markers of mania closely resemble the physiological markers of deception as measured by polygraph instruments [6]Verified Heart rate variability in bipolar mania and schizophrenia
Confirms manic BD patients demonstrated significant reduction in HRV, parasympathetic activity, and cardiac entropy compared to healthy controls [8]Verified Federal Psychophysiological Detection of Deception Examiner Handbook
Standardized testing procedures, scoring methods, and quality assurance requirements for federal polygraph programs.

Consider the standard comparison question test format, such as the Utah Zone Comparison Test (UZCT): the examiner compares physiological responses to relevant questions against responses to comparison questions. In a typical truthful examinee, responses to comparison questions should be stronger than responses to relevant questions. In a manic examinee, however, the generalized sympathetic hyperactivation may produce uniformly elevated responses across all question types, or the arousal may produce stronger responses to relevant questions simply due to the attentional capture of emotionally charged stimuli, not due to deception.

Research has demonstrated that interrogative approaches aimed at extracting confessions rather than diagnostic truth assessment can significantly compromise polygraph validity and lead to false positives [13]Verified Examiner Approach and its Impact on Polygraph Results
Confirms interrogative approaches aimed at confessions rather than diagnostic assessment compromise polygraph validity and increase false positives. This risk is compounded in manic examinees whose emotional hyper-reactivity to charged content creates an additional confound that standard polygraph scoring systems are not designed to accommodate.

Behavioral Indicators of Mania During Pre-Test

Examiners should be trained to recognize the behavioral signs of mania during the pre-test interview phase, even when the examinee has not disclosed a bipolar diagnosis. Key indicators include:

Pressured speech: Talking rapidly, loudly, and with difficulty being interrupted, often jumping from topic to topic (flight of ideas). Grandiosity: Expressing inflated self-importance, unrealistic beliefs about abilities, or disproportionate confidence about the test outcome. Decreased need for sleep: Reporting sleeping very few hours yet feeling energetic and alert. Increased goal-directed activity: Appearing hyperactive, fidgety, or unable to sit still comfortably. Distractibility: Having difficulty maintaining focus on the examiner's questions and being easily drawn to irrelevant stimuli. Irritability: Responding with disproportionate frustration or hostility to routine pre-test questions or procedures. Poor judgment: Making inappropriate comments, being overly familiar, or exhibiting impulsive behavior.

If an examiner observes multiple manic indicators, testing should not proceed. The examiner should document the observations, explain that the examination is being deferred due to suitability concerns, and recommend that the examinee consult with their treating provider before rescheduling. For detailed guidance on managing challenging situations, see our guide to handling difficult examinees. This aligns with the examiner's ethical obligation to ensure valid testing conditions, as outlined in general guidance on how to prepare for a lie detector test.

The Autonomic Profile of Bipolar Depression

While manic episodes produce more dramatic and visible challenges for polygraph testing, depressive episodes present equally significant, if more subtle, problems. Bipolar depression is associated with a pattern of autonomic hypoactivation that can be just as detrimental to polygraph validity as the hyperactivation seen in mania.

Reduced electrodermal activity: Depressive states are associated with decreased skin conductance levels and reduced electrodermal reactivity to stimuli. A 2024 study using wearable EDA monitoring at the Hospital Clinic de Barcelona confirmed that patients with bipolar depression showed significantly reduced mean EDA (p = 0.003), which increased to levels similar to euthymia or healthy controls after clinical remission [12]Verified Electrodermal activity in bipolar disorder: Differences between mood episodes and clinical remission
Confirms bipolar depression showed significantly reduced EDA that increased after remission; manic patients showed significant reduction of EDA after remission. This means that the EDA channel, often considered the most sensitive polygraph measurement [10]Verified Relative Accuracy of Polygraph Examiner Diagnosis of Respiration, Blood Pressure, and GSR Recordings
Confirms electrodermal (GSR) measures provide the most diagnostic information, followed by cardiovascular and respiratory channels, may produce muted or absent responses to both relevant and comparison questions, making differentiation impossible.

Blunted cardiovascular responses: Depressed individuals often show reduced heart rate variability and diminished cardiovascular reactivity to psychological stressors. The Faurholt-Jepsen et al. (2017) state-related HRV study found a negative correlation between severity of depressive symptoms and HRV [14]Verified State-related differences in heart rate variability in bipolar disorder
Confirms HRV was increased during manic states compared with depressive and euthymic states; negative correlation between HRV and depressive severity.

Altered respiratory patterns: Bipolar depression may be associated with shallow, slow breathing patterns or frequent sighing. While sighing can sometimes be confused with the respiratory suppression used in polygraph scoring, the overall pattern of respiratory blunting reduces the channel's diagnostic utility.

Psychomotor retardation: Severe depression can produce physical slowing, including slowed speech, reduced facial expression, and diminished body movement. While this reduces movement artifact (unlike mania), the overall reduction in autonomic responsiveness is equally problematic.

False Negative and Inconclusive Risk

The primary risks during depressive episodes are false negative results (a deceptive individual incorrectly classified as truthful) and inconclusive outcomes (insufficient physiological differentiation to make any determination). Both outcomes undermine the purpose of the examination.

False negatives may occur because the emotional and autonomic blunting of depression reduces the anxiety-driven sympathetic response that normally accompanies deception. An individual who might produce clear physiological indicators of deception when euthymic may show minimal or no differential responses during a depressive episode, causing a deceptive result to be scored as non-deceptive.

Inconclusive results are perhaps even more common because the overall flattening of physiological responses means that the mathematical criteria used in numerical scoring systems cannot achieve the threshold differences required for a definitive determination. When an examiner encounters consistently low-amplitude responses across all channels and question types, the appropriate outcome is often "inconclusive," which provides no useful information and may necessitate a follow-up examination. The Polygraph Validation Test (PVT) can be a valuable tool in resolving conflicted or unclear results in some cases [15]Verified Using the Polygraph Validation Test (PVT) in Solving Conflicted Polygraph Results
Confirms PVT successfully resolved all 51 cases of conflicted polygraph results.

These findings align with broader research on how conditions like PTSD affect polygraph testing, where autonomic dysregulation similarly creates interpretive challenges.

Recognizing Depressive States During Pre-Test

Identifying depression may be more challenging than identifying mania because depressive symptoms are less behaviorally conspicuous and can be mistaken for nervousness or fatigue. Examiners should watch for: flat affect (minimal emotional expression, monotone voice, reduced eye contact); psychomotor slowing (slow movements, delayed responses to questions, appearing lethargic); cognitive impairment (difficulty concentrating, requesting questions be repeated); anhedonia (expressing indifference about the test outcome or life events generally); hopelessness or negativity (making self-deprecating comments or expressing beliefs that the outcome is predetermined); sleep disturbance (reporting excessive sleep or severe insomnia); and appetite or weight changes.

When significant depressive symptoms are observed, the examiner must weigh whether the individual's autonomic responsiveness is sufficient to produce valid data. Research has documented that examinee distress levels during polygraph examinations vary significantly, and examinees with pre-existing depressive conditions may experience the examination process differently [16]Verified Examinee Assessment of Distress Caused by Polygraph Examination
Provides empirical data on examinee-reported distress levels during polygraph examinations. In many cases, moderate-to-severe bipolar depression warrants deferral of the examination until the depressive episode remits.

Mixed Feature Episodes

The DSM-5 recognizes a "with mixed features" specifier that can be applied to manic, hypomanic, or depressive episodes. Mixed features involve the co-occurrence of manic and depressive symptoms during the same episode, such as experiencing grandiosity and pressured speech alongside tearfulness, guilt, and suicidal ideation simultaneously [1]Verified Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Confirms diagnostic criteria for Bipolar I, Bipolar II, Cyclothymic Disorder, and mixed features specifier.

Mixed feature episodes present the most complex scenario for polygraph testing because the autonomic profile is unpredictable. The simultaneous activation and suppression of different autonomic pathways can produce erratic physiological data that defies standard interpretation. One moment the examinee may show heightened EDA and elevated heart rate (reflecting manic activation), and the next moment may show suppressed cardiovascular reactivity (reflecting depressive blunting). This intra-session variability makes it virtually impossible to establish a reliable physiological baseline.

Examiners should consider mixed feature episodes as a contraindication for testing and defer the examination until the episode resolves to a more defined mood state.

Rapid Cycling

Rapid cycling is defined as four or more mood episodes within a 12-month period. Individuals with rapid cycling bipolar disorder present a scheduling challenge because the window of euthymic stability may be narrow or unpredictable.

For examinees with rapid cycling, closer coordination with the treating mental health provider is essential to identify periods of relative stability. The examiner should confirm euthymic status as close to the testing date as possible, ideally with documentation from the treating clinician. If stability cannot be confirmed, testing should be deferred.

The Lancet Regional Health has noted that early-onset bipolar disorder cases face the highest disease burden and incident risk [5]Verified Bipolar disorders: an update on critical aspects
Confirms average age of onset peaks at 17, 26, and 42 years, and that prevalence has risen 59.3% since 1990, and these individuals are more likely to experience rapid cycling patterns, making careful timing of polygraph examinations even more important.

Lithium

Lithium is the gold standard mood stabilizer for bipolar disorder. From a polygraph perspective, lithium can affect cardiac conduction and has been associated with changes in QTc intervals [17]Verified Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar patients
Confirms autonomic nervous system is influenced by valproate and lithium-valproate combination therapy in bipolar disorder. Lithium at therapeutic levels generally produces modest autonomic effects that experienced examiners can account for during baseline establishment. The key concern is ensuring that lithium levels are within the therapeutic range, as toxicity can produce tremor, cognitive impairment, and cardiovascular irregularities that would compromise test validity.

Examiners should document lithium use and inquire about recent blood level monitoring. If the examinee reports symptoms of lithium toxicity (severe tremor, confusion, nausea, irregular heartbeat), testing should be deferred.

Valproate (Depakote) and Other Anticonvulsant Mood Stabilizers

Valproate is commonly used for bipolar disorder, particularly for acute mania. Research indicates that the autonomic nervous system is considered to be influenced by valproate therapy [17]Verified Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar patients
Confirms autonomic nervous system is influenced by valproate and lithium-valproate combination therapy in bipolar disorder. Case reports have documented that valproate can occasionally produce cardiovascular effects including blood pressure elevation in some individuals [18]Verified Valproate Induced Hypertensive Urgency
Documents case of valproate-associated cardiovascular effects including elevated blood pressure and rapid heart rate. Anticonvulsant mood stabilizers like lamotrigine and carbamazepine may also have autonomic effects, though typically mild at therapeutic doses.

While anticonvulsant medications can potentially alter autonomic function, research suggests these effects may actually help improve cardiac autonomic function by stabilizing underlying seizure-related or mood-related dysregulation [19]Verified Effects of antiepileptic drug therapy on heart rate variability in children with epilepsy
Confirms that seizure control with antiepileptic drugs may help improve cardiac autonomic function impairment. Examiners should document all anticonvulsant medications and dosages.

Atypical Antipsychotics

Atypical antipsychotics (quetiapine, olanzapine, aripiprazole, lurasidone) are increasingly used in bipolar disorder treatment. Several of these medications can produce dose-dependent effects on the autonomic nervous system, including impacts on heart rate variability [20]Verified Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: A systematic review and meta-analysis
Comprehensive review of how psychotropic medications affect autonomic nervous system function across psychiatric disorders. The literature on HRV in bipolar disorder has identified psychotropic medication effects as a significant confounding variable in studies of autonomic function [11]Verified Heart rate variability in bipolar disorder: A systematic review and meta-analysis
Confirms HRV was significantly reduced in BD compared to healthy controls (g=-1.77), based on 15 articles and 2,534 individuals.

Some atypical antipsychotics may cause sedation, which could reduce overall autonomic reactivity and potentially contribute to flat physiological profiles during testing. Others may affect blood pressure regulation. Examiners should be familiar with common psychotropic medication effects and consider them when interpreting test data.

The Federal Psychophysiological Detection of Deception Examiner Handbook provides standardized procedures that include guidance on documenting medication use and evaluating its potential impact on test results [8]Verified Federal Psychophysiological Detection of Deception Examiner Handbook
Standardized testing procedures, scoring methods, and quality assurance requirements for federal polygraph programs.

Documentation Requirements

Examiners should document all medications the examinee is currently taking, including dosages and timing of last dose. This documentation serves multiple purposes: it provides context for interpreting physiological data, it helps explain any unusual baseline patterns, and it creates a record that supports the validity of the examination. It also provides a basis for quality assurance review by other qualified examiners [8]Verified Federal Psychophysiological Detection of Deception Examiner Handbook
Standardized testing procedures, scoring methods, and quality assurance requirements for federal polygraph programs [9]Verified The Reliability of Polygraph Examiner Diagnosis of Truth and Deception
Seminal study demonstrating high inter-rater reliability for experienced examiners using structured scoring methods.

The critical point is that medication use alone does not disqualify someone from polygraph testing. What matters is whether the examinee's current physiological state, as influenced by both the underlying condition and its treatment, permits the collection of interpretable data.

The APA Standards of Practice on Suitability

The American Polygraph Association's Standards of Practice (most recently amended August 23, 2024) state that "the examiner should make reasonable efforts to determine that the examinee is a suitable candidate for polygraph testing" and that "basic inquiries into the medical and psychological condition of the examinee should be made where allowed by law" [7]Verified APA Standards of Practice
Confirms examiners should make reasonable efforts to determine suitability and make basic inquiries into medical and psychological condition. Mental, physical, or medical conditions observable by or reasonably known to the examiner should be considered when conducting and evaluating an examination.

The APA's Model Policy for the Evaluation of Examinee Suitability further specifies that persons who are actively psychotic should not undergo polygraph testing. However, individuals may be tested when their psychiatric conditions have stabilized. Individuals diagnosed with psychotic mental health disorders should be viewed as marginally suitable for polygraph testing, and test results for these persons should be reported as qualified [7]Verified APA Standards of Practice
Confirms examiners should make reasonable efforts to determine suitability and make basic inquiries into medical and psychological condition.

Examiner training programs emphasize the core elements essential for effective assessment of suitability [21]Verified Main Features of Polygraph Examiners Training
Identifies core elements essential for effective polygraph examiner training programs, and continuing education requirements ensure examiners remain current on best practices for special populations.

Structured Suitability Assessment Steps

A thorough suitability assessment for bipolar examinees should include the following steps:

1. Pre-examination inquiry: Before the testing date, gather information about the examinee's bipolar diagnosis, current treatment, and recent mood stability. Coordinate with the referring party (attorney, treatment provider, supervising officer) to obtain relevant clinical information.

2. Current mood state assessment: During the pre-test interview, systematically assess for indicators of mania, hypomania, depression, or mixed features using the behavioral criteria outlined in this guide.

3. Medication review: Document all current medications, dosages, timing of last doses, and compliance history. Inquire about any recent medication changes.

4. Treatment compliance verification: Determine whether the examinee is currently engaged in treatment and is compliant with their medication regimen. Non-compliance significantly increases the risk of active mood episodes.

5. Clinical consultation (when indicated): If mood stability is uncertain, consult with the examinee's treating mental health provider. A brief clinical note confirming euthymic status provides valuable documentation.

6. Decision and documentation: Make a clear suitability determination (suitable, marginally suitable, or unsuitable) and document the reasoning. If testing proceeds, note any accommodations made and any limitations on result interpretation.

Adapting the Pre-Test for Bipolar Examinees

The pre-test interview is a critical phase of the polygraph examination where the examiner builds rapport, reviews questions, and establishes informed consent. For bipolar examinees, several adaptations can improve the quality of the examination.

Pace and structure: Bipolar examinees, even when euthymic, may benefit from a more structured pre-test with clear transitions between topics. This helps maintain focus and reduces the cognitive load that can trigger subtle mood-related physiological shifts.

Question review: Take additional time to ensure the examinee fully understands each question. Cognitive processing speed can be subtly affected by mood-stabilizing medications. Research on adapting polygraph examination procedures for examinees with special needs provides relevant guidance [22]Verified Testing a Deaf Mute Examinee in Costa Rica
Documents practical approaches for adapting polygraph examination procedures to accommodate examinees with special needs.

Emotional calibration: Be attentive to the examinee's emotional responses during question review. Note any disproportionate emotional reactions that might indicate mood instability not detected during the initial assessment.

The examiner's approach during the pre-test can significantly impact results. Research has demonstrated that an interrogative examiner approach aimed at extracting confessions rather than conducting a diagnostic assessment can compromise validity [13]Verified Examiner Approach and its Impact on Polygraph Results
Confirms interrogative approaches aimed at confessions rather than diagnostic assessment compromise polygraph validity and increase false positives. A neutral, supportive examiner approach is particularly important for bipolar examinees to avoid triggering mood-related physiological responses unrelated to the test issues.

Core Principles for Testing Bipolar Examinees

When conducting polygraph examinations on individuals with bipolar disorder, examiners should adhere to several core principles:

Euthymic testing: Always prioritize testing during euthymic periods. The scientific evidence clearly shows that mood state significantly affects autonomic functioning [6]Verified Heart rate variability in bipolar mania and schizophrenia
Confirms manic BD patients demonstrated significant reduction in HRV, parasympathetic activity, and cardiac entropy compared to healthy controls [11]Verified Heart rate variability in bipolar disorder: A systematic review and meta-analysis
Confirms HRV was significantly reduced in BD compared to healthy controls (g=-1.77), based on 15 articles and 2,534 individuals [12]Verified Electrodermal activity in bipolar disorder: Differences between mood episodes and clinical remission
Confirms bipolar depression showed significantly reduced EDA that increased after remission; manic patients showed significant reduction of EDA after remission, and testing during active mood episodes compromises validity.

Comprehensive documentation: Document everything related to the bipolar diagnosis, current mood state, medications, and any observed behavioral indicators. This documentation supports the examination's validity and provides context for result interpretation. Research on examiner reliability has demonstrated that structured approaches to scoring and documentation produce the highest inter-rater agreement [9]Verified The Reliability of Polygraph Examiner Diagnosis of Truth and Deception
Seminal study demonstrating high inter-rater reliability for experienced examiners using structured scoring methods.

Conservative interpretation: When testing bipolar examinees, even during euthymic periods, consider reporting results with appropriate qualifications noting the bipolar diagnosis and its potential impact on physiological data. This is consistent with the APA's guidance on marginally suitable examinees [7]Verified APA Standards of Practice
Confirms examiners should make reasonable efforts to determine suitability and make basic inquiries into medical and psychological condition.

Informed consent: Ensure the examinee understands how their condition might affect the examination and that the examiner has the ethical obligation to defer testing if suitability concerns arise.

When to Defer Testing

Testing should be deferred when the examinee presents with active manic, hypomanic, depressive, or mixed episode symptoms. Additionally, testing should be deferred when the examinee has recently changed medications and has not yet stabilized; when the examinee reports significant sleep disturbance, appetite changes, or other prodromal symptoms; when the examinee cannot maintain focus, follow instructions, or sit comfortably for the examination duration; or when coordination with the treating provider raises concerns about current stability.

Deferral is not a failure of the examination process — it is a professional decision that protects the validity of the polygraph method and the welfare of the examinee. It is analogous to deferring testing in other conditions affecting physiological response, as discussed in our guide on Parkinson's disease and polygraph testing.

Preparing for Your Polygraph with Bipolar Disorder

If you have been diagnosed with bipolar disorder and are scheduled for a polygraph examination, preparation can significantly improve your experience and the accuracy of results.

Medication compliance: Continue taking all prescribed medications as directed by your treating provider. Do not skip doses or adjust medications before the test. Mood stability is the single most important factor in polygraph accuracy for bipolar individuals.

Sleep and routine: Prioritize good sleep hygiene in the days leading up to the test. Avoid disruptions to your regular sleep schedule, as sleep disturbance can destabilize mood.

Disclose your diagnosis: Inform the examiner about your bipolar diagnosis, current medications, and recent mood stability during the pre-test interview. This information helps the examiner establish accurate baselines and interpret data correctly. Honesty about your condition supports valid results.

Know your mood state: Be honest with yourself about how you are feeling. If you are entering a mood episode, request rescheduling. A test conducted during an active episode is unlikely to produce valid results and may generate results that do not accurately reflect your truthfulness.

Avoid substances: Caffeine, alcohol, and recreational drugs can affect autonomic functioning and should be avoided before the test. This guidance applies to all examinees but is particularly important for bipolar individuals whose autonomic regulation is already affected. For more detailed preparation tips, see our 5 things to know before a lie detector test.

What to Expect During the Examination

The polygraph examination process follows standardized stages: pre-test, test, and post-test. During the pre-test phase, the examiner will discuss your medical and psychological history, review the test questions, and explain the process. This phase may take longer than usual as the examiner conducts the suitability assessment.

During the testing phase, you will be asked to sit still and answer questions with simple yes or no responses. The physiological sensors will record your responses. If the examiner notices unusual physiological patterns that may be related to your condition, they may adjust the testing procedure or, in some cases, discontinue the test.

During the post-test phase, the examiner will review the data and may discuss findings. Remember that an inconclusive result does not mean you failed — it means the data was insufficient for a definitive determination, which can occur with bipolar-related autonomic variability.

Disability Accommodations and the ADA

Bipolar disorder is generally recognized as a disability under the Americans with Disabilities Act (ADA). This means that in contexts where polygraph testing is conducted as part of employment screening (for exempted positions under the Employee Polygraph Protection Act), reasonable accommodations may be required.

Reasonable accommodations for bipolar examinees might include scheduling the test during a documented period of mood stability, providing additional breaks during the examination, allowing the examiner to consult with the examinee's treating provider, or rescheduling if the examinee presents with active symptoms.

Employers and examiners should be careful not to use a bipolar diagnosis alone as grounds for disqualification. The APA Model Policy states that there is no published research suggesting that medical or mental health conditions would necessarily interfere with the polygraph test [7]Verified APA Standards of Practice
Confirms examiners should make reasonable efforts to determine suitability and make basic inquiries into medical and psychological condition. The focus should be on the individual's current functional status, not the diagnosis itself.

Admissibility and Evidentiary Weight

In jurisdictions where polygraph results are admissible, the presence of bipolar disorder may affect the weight given to the results. Attorneys should be prepared to present evidence about the examinee's mood state at the time of testing, medication regimen, and suitability assessment conducted by the examiner.

If testing was conducted during a period of mood instability, the results may be challenged on the grounds that the physiological data was contaminated by the condition rather than reflecting truthfulness or deception. Conversely, well-documented testing during a confirmed euthymic state, with appropriate suitability documentation, strengthens the evidentiary value of the results.

PCSOT Considerations

Post-Conviction Sex Offender Testing (PCSOT) presents unique challenges when the examinee has a co-occurring bipolar diagnosis. In PCSOT programs, polygraph examinations are conducted regularly as part of supervision and treatment compliance monitoring, which means the examiner will encounter the same bipolar examinee across different mood states over time. For comprehensive background on PCSOT protocols, see our guide on PCSOT risk assessment integration.

PCSOT examiners should maintain longitudinal records of each examinee's mood state, medications, and physiological baselines across examinations. This longitudinal data provides a valuable individual reference that can help differentiate condition-related physiological changes from deception-related changes.

Coordination with the treatment team is particularly important in PCSOT settings, where the examinee is typically in active treatment with both a sex-offender treatment provider and a mental health provider for the bipolar condition. The polygraph results should be integrated with other risk assessment tools and clinical information, as discussed in our guide on PCSOT polygraph in domestic violence offender programs.

Forensic Evaluation Settings

In forensic settings, bipolar disorder may be encountered in the context of criminal investigations, fitness-for-duty evaluations, and security clearance processes. The Federal Psychophysiological Detection of Deception Examiner Handbook provides standardized procedures for federal polygraph programs that include quality assurance requirements applicable to testing individuals with psychiatric conditions [8]Verified Federal Psychophysiological Detection of Deception Examiner Handbook
Standardized testing procedures, scoring methods, and quality assurance requirements for federal polygraph programs.

Forensic examiners should be particularly meticulous in their suitability documentation, as their work products may be subject to legal scrutiny. Research has demonstrated that structured scoring methods produce the highest examiner accuracy, with studies showing accuracy of 92.4% for deceptive subjects and 95.5% for truthful subjects [23]Verified The Accuracy and Consistency of Polygraph Examiners' Diagnoses
Confirms examiner accuracy of 92.4% for deceptive subjects and 95.5% for truthful subjects using structured scoring. These accuracy figures are based on examinees without significant psychiatric conditions, underscoring the importance of ensuring suitability before applying standard scoring criteria to bipolar examinees.

Qualified Result Reporting

When testing bipolar examinees, even during euthymic periods, examiners should consider qualifying their results. A qualified result acknowledges that the examinee has a condition known to affect autonomic nervous system functioning, notes the current mood state and medication regimen, and indicates whether the data quality was sufficient for reliable scoring.

This approach is consistent with the APA's guidance on marginally suitable examinees and provides transparency for result consumers (attorneys, treatment providers, supervising officers) [7]Verified APA Standards of Practice
Confirms examiners should make reasonable efforts to determine suitability and make basic inquiries into medical and psychological condition.

Research on polygraph examiner diagnosis demonstrates that high inter-rater reliability is achievable when examiners use structured scoring methods and provide thorough documentation [9]Verified The Reliability of Polygraph Examiner Diagnosis of Truth and Deception
Seminal study demonstrating high inter-rater reliability for experienced examiners using structured scoring methods. Qualified reporting enhances rather than undermines the credibility of the examination by demonstrating the examiner's awareness of factors that could affect validity.

When Results Should Not Be Relied Upon

Results should not be relied upon when testing was conducted during an active mood episode (manic, depressive, or mixed); when the examinee's medication regimen was recently changed and stability was not confirmed; when the physiological data shows patterns consistent with mood-state-related autonomic dysregulation rather than deception-related responses; or when the examinee was unable to maintain focus, follow instructions, or comply with testing requirements due to bipolar symptoms.

In these situations, the examiner should report the results as inconclusive due to physiological data quality concerns and recommend retesting after mood stabilization. Understanding the relationship between compulsive patterns and polygraph outcomes provides additional context for interpreting results where psychological factors complicate the picture.